ArticlePDF Available

Abstract

Oxygen saturation, measured by pulse oximetry (SpO2), is a vital clinical measure. Our descriptive, cross-sectional study describes SpO2 measurements from 6289 healthy subjects from age 1 to 80 years at 15 locations from sea level up to the highest permanent human habitation. Oxygen saturation measurements are illustrated as percentiles. As altitude increased, SpO2 decreased, especially at altitudes above 2500 m. The increase in altitude had a significant impact on SpO2 measurements for all age groups. Our data provide a reference range for expected SpO2 measurements in people from 1 to 80 years from sea level to the highest city in the world.
1Thorax Month 2017 Vol 0 No 0
Figure 1 2.5th, 10th, 25th, 50th, 75th, 90th, and 97.5th SpO2 percentiles for all subjects
according to altitude. (n=6289) distributed by the following altitudes: 154 m (n=709), 562 m
(n=405), 1400 m (n=315), 2000 m (n=209), 2335 m (n=522), 2500 m (n=416), 2880 m (n=404),
3250 m (n=422), 3600 m (n=361), 3950 m (n=350), 4100 m (n=644), 4338 m (n=457), 4500 m
(n=525), 4715 m (n=251), 5100 m (n=299).
Reference values for oxygen
saturation from sea level
to the highest human
habitation in the Andes in
acclimatisedpersons
ABSTRACT
Oxygen saturation, measured by pulse
oximetry (SpO2), is a vital clinical measure. Our
descriptive, cross-sectional study describes
SpO2 measurements from 6289 healthy
subjects from age 1 to 80 years at 15 locations
from sea level up to the highest permanent
human habitation. Oxygen saturation
measurements are illustrated as percentiles. As
altitude increased, SpO2 decreased, especially
at altitudes above 2500 m. The increase in
altitude had a significant impact on SpO2
measurements for all age groups. Our data
provide a reference range for expected SpO2
measurements in people from 1 to 80 years
from sea level to the highest city in the world.
BACKGROUND
Pulse oximetry has led to a great advance-
ment in patient management offering
non-invasive estimation of arterial oxygen
saturation. It is routinely used in emergency
departments, wards, intensive care and other
medical situations. At high altitudes, physi-
ological ventilation parameters like plasma
bicarbonate are different.1 Pulse oximetry
measurements of oxygen saturation (SpO2)
are lower at altitude compared with those
at sea level. However, the expected SpO2
at a given altitude is unclear and has been
suggested as a range of values rather than a
specific number.2
METHODS
Subjects
Data were collected from 15 locations
at different altitudes from sea level to
the highest permanent human habitation
located in a remote area at 5100 m in
Puno, Peru, a city named La Rinconada.3
We recruited subjects between 1 and 80
years with a minimum of 2 months resi-
dence at the place of evaluation because
alveolar gas composition is different after
acclimatisation.4 Exclusion criteria were
based on history and clinical examination.
Subjects with a history of the following
were excluded: habitual smoker (≥1 ciga-
rette day), ongoing pregnancy, chronic
cardiorespiratory disease, anaemia, poly-
cythaemia or having received a blood
transfusion in the last 6 months and with
abnormal findings in physical examina-
tion. Children who were asleep at the
time of measurement of SpO2 and subjects
with painted nails or deformities in meas-
urement locations were also excluded.
Informed consent was obtained from all
subjects or their guardians.
Measurement of SpO2
SpO2 was measured using a pulse oximeter
(Nellcor 560, Hayward, California, USA),
with sensors appropriate to the weight of the
subject. SpO2 measurements were recorded
every 10 s for a total of six measurements
and the average was used to determine
SpO2 for each study subject, as described in
previous studies.5
At the end of the study, we compared
SpO2 measurements against simultaneous
measurements of arterial oxygen satura-
tion (SaO2) by arterial blood gases in 10
hospitalised patients, at sea level. The
average of (SaO2 –SpO2) was 1.48%. This
was within the expected value of ±2%
for a range of SpO2 measurements
between 70% and 100% reported by the
manufacturer.6
To assess the reproducibility of our
data, at 5100 m, we measured SpO2
twice in 23 subjects waiting 30 min
before taking the second measurement.
For this test, we used the Fingertip Pulse
Oximeter MD300C1. The average differ-
ence between SpO2 measured by the two
devices (Nellcor-MD300C1) was −0.8%.
STATISTICAL ANALYSIS
Descriptive statistics were used to summa-
rise characteristics of the subjects.
Constructing oxygen centile charts
SpO2 data were entered into Microsoft
Excel and were analysed and charted using
Stata (Intercooled 10, Stata Corp, College
Station, Texas, USA). The SpO2 centiles
were calculated using the LMS method
of Cole and Green7 8 and fitted using
the LMSChartMaker Light V.2.3 (Insti-
tute of Child Health, London, England).
These values were then used to illustrate
the 2.5th, 10th, 25th, 50th, 75th, 90th
and 97.5th centile for SpO2 for each age
group according to residential altitude
(see online supplement).
RESULTS
We studied subjects residing at 15 specific
altitudes. We initially evaluated 6601
subjects. Three hundred and twelve met
exclusion criteria. A total of 6289 subjects
were studied: 47.2% (n=2967) males and
52.8% females (n=3322). The median
(IQR) for all SpO2 measurements at each
altitude (metre) were respectively: 99
(98–99) at 154 m; 99 (98–99) at 562 m; 98
(97–99) at 1400 m; 97 (96–98) at 2000 m;
97 (96–99) at 2335 m; 96 (95–97) at
2500 m; 95 (94–96) at 2880 m; (92–95) at
3250 m; 92 (90–93) at 3600 m; 90 (88–91)
at 3950 m; 87 (85–89) at 4100 m; 87
(85–89) at 4338 m; 87 (85–89) at 4500 m;
Research Letter
Thorax Online First, published on October 20, 2017 as 10.1136/thoraxjnl-2017-210598
Copyright Article author (or their employer) 2017. Produced by BMJ Publishing Group Ltd (& BTS) under licence.
group.bmj.com on October 23, 2017 - Published by http://thorax.bmj.com/Downloaded from
2Thorax Month 2017 Vol 0 No 0
Figure 2 2.5th, 10th, 25th, 50th, 75th, 90th, and 97.5th SpO2 percentiles for children. (A) Represents children 1–5 years (n=994) with N for specific
altitude in the same order as figure1 (n=64, 91, 69, 26, 70, 87, 95, 140, 30, 46, 91, 47, 36, 28, 74). (B) Represents children 6–17 years (n=2379)
(n=281, 144, 146, 116, 171, 234, 122, 181, 117, 202, 117, 126, 121, 133, 168). Adults 18–50 (C) (n=2195) (n=310, 120, 28, 40, 239, 70, 134, 56, 136,
45, 297, 247, 353, 68, 52) and 51–80 years (D) (n=721) (n=54, 50, 72, 27, 42, 25, 53, 45, 78, 57, 139, 37, 15, 22, 5), adults according to altitude.
Research Letter
85(83–88) at 4715 m; 81 (78–84) at 5100 m.
Oxygen saturation measurements
SpO2 measurements illustrated as percen-
tiles are shown for all subjects in figure 1,
and by age group (1–5, 6–17, 18–50 and
51–80 years) in figure 2. The figures
show that for all age groups, as altitude
increased, SpO2 decreased, especially
at altitudes above 2500 m (see online
supplement tables).
DISCUSSION
We obtained measurements from over
6000 subjects, from 1 to 80 years old,
from sea level to the highest permanent
human habitation located in Peru at
5100 m.3 This is the first study to provide
reference charts for the expected range
of SpO2 measurements by age group and
altitude using centiles by the LMS method.
We have shown the expected reduc-
tion of SpO2 with altitude, an effect that
is more evident at altitudes over 2500 m.
We have also shown increased variability
in the range of SpO2 measurements at
higher altitudes. Our observation could
be explained by a genetic variability in the
hypoxic ventilatory response. It is note-
worthy that at 5100 m, the median SpO2
of 81% could correspond to a PO2 less
than 50 mm Hg according to the oxygen
dissociation curve. This is less than half of
the normal PO2 at sea level.
Pulse oximetry utility in clinical care
outside the operating theatre has been
supported by studies at sea level and at high
altitude.9 Having a reference value for SpO2
is needed in clinical management at high
altitude locations.
There are some limitations to our find-
ings and analysis. We did not enrol subjects
over 80 years or children less than 1 year.
Our study does not apply to non-acclima-
tised individuals. We did take a clinical
history and conducted a physical exami-
nation of all subjects. However, we did
not conduct further testing, such as chest
radiography, spirometry or haemoglobin
measurement, to rule out pathology not
evidenced by clinical examination. There-
fore, in evaluating patients at high altitude,
their history and clinical presentation must
be incorporated into deciding whether an
individual SpO2 measurement should raise
concern for a patient at their usual resi-
dential altitude.
All our subjects were Andean Natives and
Hispanics and care should therefore be taken
in applying these results to other ethnicities
and to other parts of the world. For example,
Tibetans have different physiological traits
for the oxygen delivery process10 and might
have different SpO2 measurements at the
same altitude as our subjects.
In conclusion, our data provide a refer-
ence range for SpO2 in people from 1 to 80
years from sea level to the highest city in the
world, contributing to global knowledge of
expected SpO2 measurements at any given
habitable altitude.
Jose Rojas-Camayo,1 Christian Richard Mejia,2
David Callacondo,3 Jennifer A Dawson,4
Margarita Posso,5 Cesar Alberto Galvan,6
Nadia Davila-Arango,7 Erick Anibal Bravo,8
Viky Yanina Loescher,9
Magaly Milagros Padilla-Deza,10
Nora Rojas-Valero,11 Gary Velasquez-Chavez,12
Jose Clemente,13 Guisela Alva-Lozada,14
Angel Quispe-Mauricio,15 Silvana Bardalez,16
Rami Subhi17
1Instituto de Investigaciones de la Altura, Universidad
Peruana Cayetano Heredia, Lima, Peru
2Escuela de Medicina Humana, Universidad Continental,
Huancayo, Peru
3School of Medicine, Faculty of Health Sciences.,
Universidad Privada de Tacna., Tacna, Peru
4The Royal Women’s Hospital, Melbourne, Australia
5Department of Epidemiology and Evaluation, Hospital
del Mar Medical Research Institute, Barcelona, Spain
6Centro de Referencia Nacional de Alergia, Asma e
Inmunologia (CERNAAI), Instituto Nacional de Salud
del Niño, Lima, Peru
7Hospital Clínico Universitario de Salamanca,
Salamanca, Spain
group.bmj.com on October 23, 2017 - Published by http://thorax.bmj.com/Downloaded from
3Thorax Month 2017 Vol 0 No 0
Research Letter
8Hospital Nacional Dos de Mayo, Institute of Clinical
Research, Lima, Peru
9Mount Sinai Medical Center, Miami, USA
10Resocentro, Lima, Peru
11Hospital Nacional Guillermo Almenara Irigoyen, Lima,
Peru
12Centro de Salud Zalfonada, Zaragoza, Spain
13Hospital Nacional Hipólito Unanue, Lima, Peru
14Hospital Nacional Edgardo Rebagliati Martins, Lima,
Peru
15Hospital Universitario Príncipe de Asturias, Madrid,
Spain
16Clinica Concebir, Lima, Peru
17Center for international Child Health, University
of Melbourne, Royal Children’s Hospital, Melbourne,
Australia
Correspondence to Dr Jose Rojas-Camayo,
Universidad Peruana Cayetano Heredia, Lima 31, Peru;
joserojas18@ hotmail. com
Contributors All authors were involved in the design
of the study and collection of clinical data. JAD, JRC
and CRM performed the data analysis. JRC, CRM, DC,
JAD, MP, VYL and RS drafted the final manuscript and
all authors reviewed and made amendments.
Competing interests None declared.
Patient consent Obtained.
Ethics approval Ethics Committee at Hospital
Nacional Docente Madre Niño San Bartolomé, Lima-
Peru.
Provenance and peer review Not commissioned;
externally peer reviewed.
© Article author(s) (or their employer(s) unless
otherwise stated in the text of the article) 2017. All
rights reserved. No commercial use is permitted unless
otherwise expressly granted.
Additional material is published online only. To
view please visit the journal online (http:// dx. doi. org/
10. 1136/ thoraxjnl- 2017- 210598)
To cite Rojas-CamayoJ, MejiaCR, CallacondoD, etal.
Thorax Published Online First: [please include Day
Month Year]. doi:10.1136/thoraxjnl-2017-210598
Received 5 June 2017
Revised 6 September 2017
Accepted 25 September 2017
Thorax 2017;0:1–3.
doi:10.1136/thoraxjnl-2017-210598
RefeRences
1 Ramirez-Sandoval JC, Castilla-Peón MF, Gotés-
Palazuelos J, et al. Bicarbonate values for healthy
residents living in cities above 1500 meters of altitude:
a theoretical model and systematic review. High Alt
Med Biol 2016;17:85–92.
2 Luks AM, Swenson ER. Pulse oximetry at high altitude.
High Alt Med Biol 2011;12:109–19.
3 West JB. Highest permanent human habitation. High
Alt Med Biol 2002;3:401–7.
4 Rahn H, Otis AB. Man’s respiratory response during
and after acclimatization to high altitude. Am J Physiol
1949;157:445–62.
5 Beall CM, Almasy LA, Blangero J, et al. Percent of
oxygen saturation of arterial hemoglobin among
Bolivian Aymara at 3,900–4,000 m. Am J Phys
Anthropol 1999;108:41–51.
6 Covidien. Operator’s Manual. OxiMax N-560. pulse
oximeter . http://www. medtronic. com/ content/ dam/
covidien/ library/ us/ en/ product/ pulse- oximetry/ N560_
OperatorsManual_ EN_ 10096204A00. pdf (accessed
23 July 2017).
7 Cole TJ, Green PJ. Smoothing reference centile curves:
the LMS method and penalized likelihood. Stat Med
1992;11:1305–19.
8 Cole TJ. Fitting smoothed centile curves to reference
data. J R Stat Soc Ser A Stat Soc 1988;151:385–418.
9 Reuland DS, Steinhoff MC, Gilman RH, et al.
Prevalence and prediction of hypoxemia in children
with respiratory infections in the Peruvian Andes. J
Pediatr 1991;119:900–6.
10 Beall CM. Two routes to functional adaptation: Tibetan
and Andean high-altitude natives. Proc Natl Acad Sci U
S A 2007;104 Suppl 1:8655–60.
group.bmj.com on October 23, 2017 - Published by http://thorax.bmj.com/Downloaded from
the Andes in acclimatised persons
sea level to the highest human habitation in
Reference values for oxygen saturation from
Alva-Lozada, Angel Quispe-Mauricio, Silvana Bardalez and Rami Subhi
Nora Rojas-Valero, Gary Velasquez-Chavez, Jose Clemente, Guisela
Padilla-Deza,Erick Anibal Bravo, Viky Yanina Loescher, Magaly Milagros
Davila-Arango,A Dawson, Margarita Posso, Cesar Alberto Galvan, Nadia
Jose Rojas-Camayo, Christian Richard Mejia, David Callacondo, Jennifer
published online October 20, 2017Thorax
8
http://thorax.bmj.com/content/early/2017/10/20/thoraxjnl-2017-21059
Updated information and services can be found at:
These include:
References
#BIBL8
http://thorax.bmj.com/content/early/2017/10/20/thoraxjnl-2017-21059
This article cites 9 articles, 0 of which you can access for free at:
service
Email alerting box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in the
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on October 23, 2017 - Published by http://thorax.bmj.com/Downloaded from
... The odds of death doubled at SpO 2 of 94-95% compared with 98-100%, almost tripled at 92-93%, quadrupled at 90-91%, and increased 6-fold at 88-89% (figure). This pattern is almost identical when restricting to the four primary-care or outpatient-care studies or the two inhospital studies and remains robust in a sensitivity analysis that equally weights all studies (appendix pp 8,9). These data show SpO 2 as a potent tool for risk stratification, with odds of death increasing with decreasing SpO 2 similarly across diverse inpatient and outpatient populations. ...
... Fitted exponential trend lines show ORs overall and by facility type (ie, individuals in primary care and outpatient care vs individuals admitted to health facility). An extended graph, including SpO 2 less than 86%, is available in the appendix (pp 8,9). OR=odds ratio. ...
Article
Full-text available
Pulse oximeters are essential for assessing blood oxygen levels in emergency departments, operating theatres, and hospital wards. However, although the role of pulse oximeters in detecting hypoxaemia and guiding oxygen therapy is widely recognised, their role in primary care settings is less clear. In this Viewpoint, we argue that pulse oximeters have a crucial role in risk-stratification in both hospital and primary care or outpatient settings. Our reanalysis of hospital and primary care data from diverse low-income and middle-income settings shows elevated risk of death for children with moderate hypoxaemia (ie, peripheral oxygen saturations [SpO2] 90–93%) and severe hypoxaemia (ie, SpO2 <90%). We suggest that moderate hypoxaemia in the primary care setting should prompt careful clinical re-assessment, consideration of referral, and close follow-up. We provide practical guidance to better support front-line health-care workers to use pulse oximetry, including rethinking traditional binary SpO2 thresholds and promoting a more nuanced approach to identification and emergency treatment of the severely ill child.
... Nos casos em que diferenças estatisticamente significativas entre as avaliações foram observadas, o tamanho de efeito (Cohen d) e diferenças médias com intervalos de confiança (IC) de 95% foram relatadas. Este estudo se concentrou em um grupo específico de jovens sem doenças neurológicas ou psiquiátricas prévias que tivessem pressão arterial, saturação de oxigênio 19 , peso 20 e força muscular de preensão manual 21 normais. Eles foram escolhidos porque este estudo é uma das primeiras tentativas de avaliar testes baseados em desempenho em um ambiente aquático. ...
Article
Full-text available
RESUMO: O objetivo deste estudo foi investigar a viabilidade, os benefícios e os desafios do uso do ambiente aquático para avaliar testes funcionais na comparação com avaliações realizadas em solo. Neste estudo, 40 indivíduos foram submetidos ao teste de caminhada de seis minutos (TC6), ao teste de subida de degraus de dois minutos (TSD2’) e ao teste timed-up-and-go (TUG), tanto em solo quanto em uma piscina de 1,2 metros de profundidade. O esforço dos participantes foi medido pela escala de Borg. Testes t de Student e Cohen d foram usados para comparar avaliações entre ambientes. Significância foi estipulada em 5%. Em comparação com o teste em solo, os participantes caminharam menos na água durante o TC6 (d=3,69, p<0,001) e levaram mais tempo para completar o TUG (d=2,76, p=0,001). Não foram observadas diferenças no esforço entre ambientes para o TC6 (p=0,055) e o TUG (p=0,32). Em relação ao TSD2’, não houve diferença no número de degraus entre ambientes (p=0,45) e os participantes experimentaram um menor esforço na água (d=1,15, p=0,001). Em conclusão, ambientes aquáticos são uma opção viável para realizar testes funcionais. Embora a água possa ter aumentado a dificuldade de certos testes, o esforço na água foi igual ou menor do que em solo.
... SpO 2 is widely used in clinical practice to monitor hypoxia status, whose reduction has been linked to the increased risk of hypoxemia, acute heart failure, 50 and mortality. 51 SpO 2 levels in our participants were lower than sea level norms (95%w100%), but they were comparable to 52,53 or modestly lower than 52 levels reported at similar altitudes. We observed that acute O 3 exposure was associated with significant decrements in SpO 2 , ...
Article
Full-text available
Background Epidemiological studies reported associations between ozone (O3) exposure and cardiovascular diseases, yet the biological mechanisms remain underexplored. Hypoxia is a shared pathogenesis of O3-associated diseases; therefore, we hypothesized that O3 exposure may induce changes in hypoxia-related markers, leading to adverse cardiovascular effects. Objectives This study aimed to investigate associations of short-term O3 exposure with hypoxic biomarkers and arterial stiffness. Methods We conducted a panel study involving 210 young healthy residents in 2 cities at different altitudes on the Qinghai-Tibetan Plateau in China, where O3 concentrations are high and particulate pollution is low. Participants underwent 4 repeated visits to assess ambient O3 exposure levels, hypoxic biomarkers, and arterial stiffness. We applied linear mixed-effects models to assess the associations of O3 exposure (lag1 to lag1-7 days) with hypoxic biomarkers and arterial stiffness, adjusted for confounders. Mediation analyses explored the hypoxia’s role in O3-related arterial stiffness changes. We further examined effect modification by residence altitude and the robustness of results by including PM2.5 (particulate matter ≤2.5 μm in aerodynamic diameter) or NO2 in 2-pollutant models. Results O3 exposure 1 to 7 days before visits was significantly associated with changes in multiple hypoxic biomarkers. A 10-ppb increase in O3 exposure was linked to significant decreases in oxygen saturation (SpO2) and increases in red blood cell count (RBC), hemoglobin concentration, and hematocrit, with maximum changes by −0.42%, 0.92%, 0.97%, and 1.92%, respectively. Laboratory analysis of mRNA and protein markers consistently indicated that O3 exposure activated the hypoxia-inducible factor 1 (HIF-1) signaling pathway. Additionally, a 10-ppb increase in O3 corresponded to a 1.04% to 1.33% increase in carotid-femoral pulse wave velocity (cfPWV), indicating increased arterial stiffness. RBC, hemoglobin concentration, and hematocrit increases significantly mediated the O3–cfPWV association, whereas the SpO2 reduction had an insignificant mediating effect. Associations of O3 with hypoxic biomarkers varied by altitude. The higher altitude group showed delayed associations with SpO₂ and HIF-1 expression but stronger associations with RBC indices. These associations remained robust after adjusting for copollutants. Conclusions O3 exposure may reduce oxygen availability, prompting compensatory increases in red blood cells and hemoglobin, which exacerbate arterial stiffening. These findings provide new insights into the mechanisms underlying O3-induced cardiovascular injury.
... Recalibration of the sensor (Fig. 10) reduced the overestimation of SpO2 values at low range and improved accuracy. This is very important in different applications of elite and endurance athletes, where SpO2 varies in a large range [32], [33], [34], [35]. The optical response to declining blood oxygen level varies between individuals and this variation cannot be explained by skin tone in this study. ...
Article
Full-text available
Objective: This paper describes the full development of a sensor for measuring optical heart rate (OHR) and blood oxygen saturation (SpO2). Methods: A wearable sensor with a new type of skin compatible dispensed lens was designed and manufactured. All critical optical components, light emitting diodes (LEDs) and photodiode (PD) were close to skin and gave maximum light intensity due to minimal loss in the lens structure. Lens and optical components formed a thin monolithic structure. Results: Suppressed crosstalk between LED and PD was achieved by using two types of dispensed material: light blocking and transparent. High signal to noise ratio (SNR) and amplitude in the alternating current (AC) part of the photoplethysmography (PPG) signal were achieved. User comfort was achieved by having a small sensor located on the upper arm. When re-training the algorithm from our first iteration, the multiwavelength PPG sensor showed an SpO2 RMSE of 2.61% with a 7-second average analysis for 25 participants. The average RMSE of heart rate over all 25 participants was 1.6 ± 1.1%. Conclusion: This study demonstrates a sensor with a clinical grade SpO2 measurement and a highly accurate OHR measurement that is also comfortable and easy to wear. Significance: A dispensing method provides a new way of manufacturing sensor elements for wearable sensors with increased performance with reduced crosstalk.
... A mayor altitud de residencia disminuye la presión parcial de oxígeno y por ende los valores obtenidos mediante oximetría de pulso. Este efecto es marcado en alturas de más de 2500 metros sobre el nivel del mar (msnm) (22) . El tamizaje neonatal de cardiopatías congénitas críticas en la altura trae retos fisiológicos a tomar en cuenta, ya que la respuesta ventilatoria hipóxica es menor en poblaciones andinas, los niveles de hemoglobina y volúmenes pulmonares son mayores, la gradiente alveolo arterial es muy estrecha y existe una respuesta vasoconstrictora pulmonar hipóxica menos marcada (23) . ...
Article
Full-text available
Congenital heart diseases are the most common congenital malformations worldwide and represent one of the leading causes of neonatal death, in addition to the significant use of human and financial resources by health systems. The purpose of this document is to support the implementation of neonatal screening for critical congenital heart diseases using pulse oximetry according to the different geographical altitudes of Peru. This technology is widely used worldwide and has high sensitivity, specificity, and cost-effectiveness. At many latitudes, it has led to better survival in this group of patients and in the neonatal population in general since its use in the early detection of sepsis, pneumonia, and other conditions that affect the oxygenation of the newborn. Neonatal screening for critical congenital heart disease is applicable at all levels of healthcare at a national level, and its implementation must be a priority to improve neonatal health.
Article
Full-text available
This study aimed to investigate the feasibility, benefits, and challenges of using aquatic environment to assess physical function tests compared with land-based assessments. A total of 40 individuals underwent the 6-minute walk test (6MWT), 2-minute step test (2MST), and timed get-up-and-go (TUG) test, both on land and in a 1.2-meter water depth pool. Perceived exertion was measured using the Modified Borg scale. Paired Student’s t-tests and Cohen d were used to compare assessments in water and on land . Significance was set at 5%. Compared to land, participants walked less in water during the 6MWT (d =3.69, p<0.001) and took longer to complete the TUG test (d =2.76, p=0.001). No differences were observed in perceived exertion between land and water during the 6MWT (p=0.055) and TUG test (p=0.32). Regarding 2MST, there was no difference in performance between the environments (p=0.45). Conversely, participants experienced lower perceived exertion during the 2MST in water (=1.15, p=0.001). In conclusion, an aquatic environment is a feasible option for conducting functional tests. Although water may have increased the difficulty of certain assessments, the perceived exertion in water was either lower than or comparable to that of land.
Article
Objectives We evaluated the Phoenix criteria and the Phoenix Sepsis Score in a multicenter retrospective cohort of critically ill children with a clinical diagnosis of sepsis or septic shock in Bolivia. In addition, we aimed to assess whether management in a PICU at high altitude in the Bolivian Andes was associated with the performance of the respiratory dysfunction component in the Phoenix Sepsis Score. Design Multicenter retrospective cohort study. Setting Fourteen PICUs in Bolivia. Patients Children admitted to the PICU with a clinical diagnosis of sepsis or septic shock from January 2023 to December 2023. Interventions None. Measurements and Main Results There were 273 patients with a diagnosis of sepsis in 2023, of which 257 (94.1%) met the 2024 Phoenix criteria for sepsis, and 166 (60.8%) met the systemic inflammatory response syndrome (SIRS)-based criteria for sepsis. Among the 257 patients meeting Phoenix sepsis criteria, 86 died (33.5%). Of the patients with Phoenix-based sepsis, there were 100 of 257 (38.9%) who were SIRS-negative, and 27 of 100 died (27.0%). After correcting the oxygenation indices for altitude, 149 of 273 patients (54.6%) had a lower Phoenix respiratory score and an associated mortality more consistent with the expected mortality of the newly derived subscore. Patients at higher altitudes had higher hemoglobin levels and higher estimated oxygen carrying capacity, and these data were independently associated with lower odds of mortality after controlling for altitude-corrected Phoenix score. Conclusions In this 2023, retrospective cohort of PICU patients with sepsis in Bolivia, we have found that the majority met the 2024 Phoenix sepsis criteria, but less than two-thirds met the SIRS-based criteria for diagnosis. However, the respiratory score in the Phoenix criteria overestimated the severity of respiratory dysfunction in more than half of the cohort, likely because the score does not take account of the Andean adaptation to high altitude, with higher oxygen carrying capacity.
Article
Background Hypoxia is a significant risk factor of hypertension. However, no studies have used transcutaneous tissue partial pressure of oxygen (TcPO 2 ) and partial pressure of carbon dioxide (TcPCO 2 ) monitors to measure the respective partial pressures in healthy individuals. Oxygen saturation (SpO 2 ) is often used for traditional monitoring of vital signs. This study investigated the changes in TcPO 2 and SpO 2 values during rapid changes in altitude. The trial was registered at ClinicalTrials.gov (registration no. NCT06076057). Methods Healthy adult volunteers were instructed to sit vertically in a hypobaric oxygen chamber, which ascended from 0 m to 2500 m at a uniform speed within 10 min. The Danish Radiometer TCM4 was used to measure TcPO 2 and TcPCO 2 with the ventral side of the upper arm as the measurement site. The Shenzhen Kerokan P0D-1 W pulse oximeter was used to measure heart rate and SpO 2 , with values recorded once every 500 m. Results Altogether, 49 healthy volunteers were recruited between March 2023 and August 2023. With increasing altitude, TcPO 2 and SpO 2 decreased significantly ( P < 0.01). During the ascent from 0 m, TcPO 2 began to change statistically at 500 m ( P < 0.05), whereas SpO 2 began to change statistically at 1000 m ( P < 0.05). At the same altitude, the difference in TcPO 2 was greater than the difference in SpO 2 . At 1000 m, there were statistically significant changes in TcPO 2 and SpO 2 ( P < 0.001). At altitudes >500 m, statistical significance was identified between TcPO 2 in both sexes ( P < 0.05). Statistical significance in TcPCO 2 and heart rate was observed at the different elevations ( P < 0.05). Conclusion In acutely changing low-pressure hypoxic environments, TcPO 2 changed more dramatically than SpO 2 .
Article
Full-text available
Ramirez-Sandoval, Juan C., Maria F. Castilla-Peón, José Gotés-Palazuelos, Juan C. Vázquez-García, Michael P. Wagner, Carlos A. Merelo-Arias, Olynka Vega-Vega, Rodolfo Rincón-Pedrero, and Ricardo Correa-Rotter. Bicarbonate values for healthy residents living in cities above 1500 m of altitude: a theoretical model and systematic review. High Alt Med Biol 00:000-000, 2016-Plasma bicarbonate (HCO3(-)) concentration is the main value used to assess the metabolic component of the acid-base status. There is limited information regarding plasma HCO3(-) values adjusted for altitude for people living in cities at high altitude defined as 1500 m (4921 ft) or more above sea level. Our aim was to estimate the plasma HCO3(-) concentration in residents of cities at these altitudes using a theoretical model and compare these values with HCO3(-) values found on a systematic review, and with those venous CO2 values obtained in a sample of 633 healthy individuals living at an altitude of 2240 m (7350 ft). We calculated the PCO2 using linear regression models and calculated plasma HCO3(-) according to the Henderson-Hasselbalch equation. Results show that HCO3(-) concentration falls as the altitude of the cities increase. For each 1000 m of altitude above sea level, HCO3(-) decreases to 0.55 and 1.5 mEq/L in subjects living at sea level with acute exposure to altitude and in subjects acclimatized to altitude, respectively. Estimated HCO3(-) values from the theoretical model were not different to HCO3(-) values found in publications of a systematic review or with venous total CO2 measurements in our sample. Altitude has to be taken into consideration in the calculation of HCO3(-) concentrations in cities above 1500 m to avoid an overdiagnosis of acid-base disorders in a given individual.
Article
Full-text available
Pulse oximetry is a valuable, noninvasive, diagnostic tool for the evaluation of ill individuals at high altitude and is also being increasingly used to monitor the well-being of individuals traveling on high altitude expeditions. Although the devices are simple to use, data output may be inaccurate or hard to interpret in certain situations, which could lead to inappropriate clinical decisions. The purpose of this review is to consider such issues in greater detail. After examining the operating principles of pulse oximetry, we describe the available devices and the potential uses of oximetry at high altitude. We then consider the pitfalls of pulse oximetry in this environment and provide recommendations about how to deal with these issues. Device users should recognize that oxygen saturation changes rapidly in response to small changes in oxygen tensions at high altitude and that device accuracy declines with arterial oxygen saturations of less than 80%. The normal oxygen saturation at a given elevation may not be known with certainty and should be viewed as a range of values, rather than a specific number. For these reasons, clinical decisions should not be based on small differences in saturation over time or among individuals. Effort should also be made to minimize factors that cause measurement errors, including cold extremities, excess ambient light, and ill-fitting oximeter probes. Attention to these and other issues will help the users of these devices to apply them in appropriate situations and to minimize erroneous clinical decisions.
Article
Full-text available
Populations native to the Tibetan and Andean Plateaus are descended from colonizers who arrived perhaps 25,000 and 11,000 years ago, respectively. Both have been exposed to the opportunity for natural selection for traits that offset the unavoidable environmental stress of severe lifelong high-altitude hypoxia. This paper presents evidence that Tibetan and Andean high-altitude natives have adapted differently, as indicated by large quantitative differences in numerous physiological traits comprising the oxygen delivery process. These findings suggest the hypothesis that evolutionary processes have tinkered differently on the two founding populations and their descendents, with the result that the two followed different routes to the same functional outcome of successful oxygen delivery, long-term persistence and high function. Assessed on the basis of basal and maximal oxygen consumption, both populations avail themselves of essentially the full range of oxygen-using metabolism as populations at sea level, in contrast with the curtailed range available to visitors at high altitudes. Efforts to identify the genetic bases of these traits have included quantitative genetics, genetic admixture, and candidate gene approaches. These reveal generally more genetic variance in the Tibetan population and more potential for natural selection. There is evidence that natural selection is ongoing in the Tibetan population, where women estimated to have genotypes for high oxygen saturation of hemoglobin (and less physiological stress) have higher offspring survival. Identifying the genetic bases of these traits is crucial to discovering the steps along the Tibetan and Andean routes to functional adaptation.
Article
A general method is described for fitting smooth centile curves to reference data, based on the power transformation family of Box and Cox. The data are defined by values or ranges of values of the independent variable t, and best fitting powers λ^i\hat\lambda_i assuming normality are estimated for each group i. Corresponding estimates for the generalized mean and coefficient of variation μ^i\hat\mu_i and σ^i\hat\sigma_i are also obtained. The λ^i,μ^i\hat\lambda_i, \hat\mu_i and σ^i\hat\sigma_i plotted against ti are fitted by smooth curves L(t), M(t) and S(t) respectively, which together define a smooth curve for the 100αth centile given by C100α(t) = M(t)[ 1 + L(t)S(t)zα]1/L(t), where zα is the normal equivalent deviate for tail area α. The method is validated by comparison with published growth standards and illustrated on weight and height data in children. A section describing the practical details of the method is also included.
Article
Refence centile curves show the distribution of a measurement as it changes according to some covariate, often age. The LMS method summarizes the changing distribution by three curves representing the median, coefficient of variation and skewness, the latter expressed as a Box-Cox power. Using penalized likelihood the three curves can be fitted as cubic splines by non-linear regression, and the extent of smoothing required can be expressed in terms of smoothing parameters or equivalent degrees of freedom. The method is illustrated with data on triceps skinfold in Gambian girls and women, and body weight in U.S.A. girls.
Article
To determine the effect of respiratory infections on oxyhemoglobin saturation in a high-altitude population, we recorded clinical signs, oxyhemoglobin saturation determined by pulse oximetry, and findings on radiographs of the chest of 423 children with acute respiratory infections; the children were living at an altitude of 3750 m in the Peruvian Andes. We defined hypoxemia as an oxyhemoglobin saturation value greater than 2 SD below the mean value for 153 well children in this population. Eighty-three percent of children with clinical bronchopneumonia, but only 10% of children with upper respiratory tract infection, had hypoxemia (p less than 0.001). Compared with previous studies of children living at lower altitudes, the presence of tachypnea was relatively nonspecific as a predictor of radiographically determined pneumonia or of hypoxemia, especially in infants. A history of rapid breathing was 74% sensitive and 64% specific in the prediction of hypoxemia, and performed as well as a standard World Health Organization case management algorithm in the prediction of radiographic pneumonia or hypoxemia. Radiographic pneumonia was not a sensitive predictor of hypoxemia or clinically severe illness. In contrast, the presence of hypoxemia was a useful predictor of radiographic pneumonia, with both sensitivity and specificity of 75% in infants. We conclude that acute lower respiratory tract infection in children living at high altitude is frequently associated with hypoxemia, and that oxygen should be administered to children with a diagnosis of pneumonia in these regions. Case management algorithms developed in low-altitude regions may have to be modified for high-altitude settings. In this setting, pulse oximetry is a good predictor of pneumonia. Because pulse oximetry is more objective and cheaper than radiography, its role as a clinical and investigative tool merits further exploration.
Article
A range of variation in percent of oxygen saturation of arterial hemoglobin (SaO2) among healthy individuals at a given high altitude indicates differences in physiological hypoxemia despite uniform ambient hypoxic stress. In populations native to the Tibetan plateau, a significant portion of the variance is attributable to additive genetic factors, and there is a major gene influencing SaO2. To determine whether there is genetic variance in other high-altitude populations, we designed a study to test the hypothesis that additive genetic factors contribute to phenotypic variation in SaO2 among Aymara natives of the Andean plateau, a population geographically distant from the Tibetan plateau and with a long, separate history of high-altitude residence. The average SaO2 of 381 Aymara at 3,900-4,000 m was 92+/-0.15% (SEM) with a range of 84-99%. The average was 2.6% higher than the average SaO2 of a sample of Tibetans at 3,800-4,065 m measured with the same techniques. Quantitative genetic analyses of the Aymara sample detected no significant variance attributable to genetic factors. The presence of genetic variance in SaO2 in the Tibetan sample and its absence in the Aymara sample indicate there is potential for natural selection on this trait in the Tibetan but not the Aymara population.
Article
The aim of this analysis was to determine the altitude of the highest permanent human habitation in the hope that this will throw some light on what determines the highest altitude that a community can tolerate indefinitely. A number of places where people have lived at very high altitudes for long periods of time are reviewed. Individuals have lived for as long as 2 yr at an altitude of 5950 m, and there was a miner's camp at 5300 m for several years. The highest permanently inhabited town in the world at the present time appears to be La Rinconada, a mining village of over 7000 people in southern Peru at an altitude of up to 5100 m, which has been in existence for over 40 yr. The altitude of the highest permanent human habitation is determined partly by economic factors, rather than solely by human tolerance to hypoxia.
Operator's Manual. OxiMax N-560
  • Covidien
Covidien. Operator's Manual. OxiMax N-560. pulse oximeter. http://www. medtronic. com/ content/ dam/ covidien/ library/ us/ en/ product/ pulse-oximetry/ N560_